PHARMACODYNAMIC EFFECTS OF ALPHA-METHYL DOPA IN HYPERTENSIVE SUBJECTS

[1] BLASCHKO H, 1959, PHARMACOL REV, V11, P307

[2] BREST AN, 1961, 2 HAHN S HYP DIS, P430

[3] CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 1011 - 1020

[4] THE CLINICAL EVALUATION OF FAULTY ORTHOSTATIC MECHANISMS [J]. MEDICAL CLINICS OF NORTH AMERICA, 1960, 44 (05) : 1237 - 1250

[5] HOLTZ P, 1959, PHARMACOL REV, V11, P317

[6] Holtz P., 1938, ARCH EXP PATHOL PH, V191, P87, DOI [10.1007/BF01994628, DOI 10.1007/BF01994628]

[7] Holtz P., 1939, NATURWISSENSCHAFTEN, V27, P724, DOI DOI 10.1007/BF01494245

[8] NOVACK P, HYPERTENSION RECENT, P444

[9] DECARBOXYLASE INHIBITION AND BLOOD PRESSURE REDUCTION BY ALPHA-METHYL-3,4-DIHYDROXY-DL-PHENYLALANINE [J]. SCIENCE, 1960, 131 (3417) : 1890 - 1891

[10] SANNERSTEDT R, 1962, ACTA MED SCAND, V171, P75

[1] BLASCHKO H, 1959, PHARMACOL REV, V11, P307

[2] BREST AN, 1961, 2 HAHN S HYP DIS, P430

[3] CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 1011 - 1020

[4] THE CLINICAL EVALUATION OF FAULTY ORTHOSTATIC MECHANISMS [J]. MEDICAL CLINICS OF NORTH AMERICA, 1960, 44 (05) : 1237 - 1250

[5] HOLTZ P, 1959, PHARMACOL REV, V11, P317

[6] Holtz P., 1938, ARCH EXP PATHOL PH, V191, P87, DOI [10.1007/BF01994628, DOI 10.1007/BF01994628]

[7] Holtz P., 1939, NATURWISSENSCHAFTEN, V27, P724, DOI DOI 10.1007/BF01494245

[8] NOVACK P, HYPERTENSION RECENT, P444

[9] DECARBOXYLASE INHIBITION AND BLOOD PRESSURE REDUCTION BY ALPHA-METHYL-3,4-DIHYDROXY-DL-PHENYLALANINE [J]. SCIENCE, 1960, 131 (3417) : 1890 - 1891

[10] SANNERSTEDT R, 1962, ACTA MED SCAND, V171, P75